Christi Waarich | Director, Investor Relations and Corporate Communications |
Robert Gould | President & CEO |
Bryan Stuart | Chief Operating Officer |
Chris Moxham | Chief Scientific Officer |
Peter Thomson | Vice President, Finance and Accounting |
Ted Tenthoff | Piper Sandler |
Joseph Schwartz | SVB Leerink |
Dae Gon Ha | Stifel |
Matthew Harrison | Morgan Stanley |
Good morning, and welcome to the Fulcrum Therapeutics Fourth Quarter and Year End 2020 Conference Call. Currently all participants are in listen-only mode. There will be a question-and-answer session at the end of this call. I would now like to turn the call over to Christi Waarich, Director of Investor Relations and Corporate Communications at Fulcrum. Please proceed.